Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioRestorative Therapies Inc BRTX

Healthcare Biotechnology
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more

Recent & Breaking News (NDAQ:BRTX)

BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors

GlobeNewswire October 26, 2021

BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program

GlobeNewswire September 23, 2021

BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program

GlobeNewswire September 2, 2021

BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program

GlobeNewswire August 31, 2021

BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook

GlobeNewswire August 19, 2021

BioRestorative Therapies Discusses Upcoming Annual Meeting of Stockholders

GlobeNewswire August 11, 2021

BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering

GlobeNewswire August 9, 2021

CEO Presenting on the Emerging Growth Conference on June 9. Register here

GlobeNewswire June 7, 2021

BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021

GlobeNewswire June 7, 2021

BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility

GlobeNewswire May 10, 2021

BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and "Stop Sign" Removal

GlobeNewswire May 3, 2021

BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors

GlobeNewswire April 5, 2021

BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program

GlobeNewswire March 31, 2021

BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program

GlobeNewswire March 22, 2021

BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K

GlobeNewswire March 18, 2021

BioRestorative Therapies Provides End of Year Shareholder Letter

GlobeNewswire January 5, 2021

BioRestorative Therapies Emerges from Chapter 11 Reorganization

GlobeNewswire November 20, 2020

BioRestorative Therapies Featured in IEEE Pulse Magazine's Cover Story About Stem Cell Therapies for Low Back Pain

GlobeNewswire December 16, 2019

BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

GlobeNewswire December 12, 2019

BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

GlobeNewswire October 23, 2019